-
Drugmakers add inactive ingredients to stabilize medications and sometimes to help the body absorb the active ingredients. But the inactive constituents can cause side effects in rare cases.
-
Lawsuits over the way drugmakers have marketed opioids are already putting a dent in companies' reputations. Litigation has forced the release of internal documents that are shifting the narrative.
-
With high drug prices a hot election issue, drugmakers and the Trump administration are jockeying over how to bring prices down. But critics say the proposed fixes don't have enforcement teeth.
-
Utah-based hospital system Intermountain Healthcare released new details today about its plan to start manufacturing its own generic drugs....
-
People with Parkinson's and related forms of dementia improved in a small study when they took a leukemia drug called nilotinib. Researchers say the drug seems to help brain cells eliminate toxins.
-
One of the most important tools of modern medicine is in jeopardy. In the 20th century, antibiotics turned once-lethal infections into manageable…
-
New and experimental drugs are extending the lives of people with the deadliest forms of cancer. At the University of Colorado Cancer Center in Aurora,…
-
This fall, the highly publicized death of Brittany Maynard, a 29-year-old with terminal brain cancer who decided to end her life, brought the "right to…
-
The U.S. Department of Defense has awarded a $2 million contract to Colorado State University’s Biopharmaceutical Manufacturing and Academic Resource…
-
Starting in June, Colorado’s Medicaid agency will cover a breakthrough hepatitis C drug on a case-by-case basis, while it decides who will qualify for the…